PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jclinpathJournal of Clinical PathologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Clin Pathol. 2007 July; 60(7): 843–844.
PMCID: PMC1995778

Histopathological features of gastrointestinal mucosal biopsy specimens in children with epidermolysis bullosa

Epidermolysis bullosa (EB) is a term used to represent a group of conditions characterised by cutaneous blistering due to abnormalities of ultrastructural components anchoring epithelial cells to either each other or to the basement membrane.1,2,3 There are a range of subtypes, which were traditionally classified on the basis of the level of the epidermal separation, more recently delineated on the basis of the underlying genetic defect.4 The vast majority of the clinical literature in these conditions is based around the cutaneous complications. There is a reported association between some subtypes of epidermolysis bullosa and pyloric stenosis,4 but there are no previous reports of mucosal histopathological features, despite these patients sometimes exhibiting significant gastrointestinal symptoms.

We report the gastrointestinal mucosal histopathological features in a series of patients with epidermolysis bullosa who underwent endoscopic evaluation for gastrointestinal symptoms at a single specialist centre.

Methods

Since 2003 it has been our policy to investigate all children seen in the epidermolysis bullosa clinic with significant abdominal symptoms by upper and lower gastrointestinal endoscopic examination with mucosal biopsies. During this three‐year period, all cases that underwent endoscopic examination with this indication were identified. The findings at the time of endoscopy were reviewed in addition to other clinical details such as basic demographic information, symptomatology, and the specific type of EB. The histopathological specimens were reviewed by a consultant paediatric pathologist who was blinded to the endoscopic findings and clinical details regarding the type of EB. Histological features of significance were recorded and compared to the clinical information. The study was approved by the local research ethics committee.

Results

During the study period there were nine patients identified in whom endoscopic examination had been carried out and mucosal biopsies performed. Table 11 presents demographic information, clinical details and a summary of the histopathological gastrointestinal findings. The mucosal biopsy specimens showed features ranging from no histological abnormalities to moderately severe inflammatory changes, such as an increase in lamina propria inflammatory cell density, including predominant eosinophils, and focal active inflammation with neutrophils present in surface epithelium. In addition, a striking finding, noted in four of the nine cases, was an abundance of karyorrhectic cellular debris located within the lamina propria beneath the surface epithelium of the colonic biopsy specimens. All these changes were exhibited in biopsy specimens from children with recessive dystrophic EB subtype. Furthermore, in three cases, patchy granular brown, pigment‐containing macrophages were also identified within the lamina propria, which stained positively with Perl's stain, indicating haemosiderin pigment deposition. In no case was morphologically apparent epidermal separation or clefting identified, and no morphological features indicating vasculitis could be seen.

Table thumbnail
Table 1 Epidermolysis bullosa (EB) subtype, clinical gastrointestinal symptoms and summarised endoscopic and positive histopathological findings in a gastrointestinal mucosal biopsy series from nine children with EB

Discussion

The findings of this study have documented, for the first time, the specific histological abnormalities identifiable on routine gastrointestinal mucosal biopsies in children with EB who experience gastrointestinal symptoms.5 The predominant pathological finding in the abnormal cases was varying degrees of inflammatory change. The mechanism of this inflammatory process in this clinical setting remains uncertain, but it is possible that the abnormal epithelial cell adhesion, both to other mucosal epithelial cells and to the underlying basement membrane, may facilitate passage of antigenic molecules across the mucosal surface to stimulate an inflammatory process. Alternatively, the underlying mechanism may be an autoimmune‐type process, with basement membrane splitting resulting in exposure of normally “hidden” antigenic components and induction of autoimmunity. Furthermore, although only present in a proportion of the cases, where identified, a most striking finding was a florid increase in the amount of colonic subepithelial lamina propria karyorrhectic debris, with or without associated haemosiderin deposition. Such a feature may occasionally be seen in other clinical settings6 in otherwise unremarkable colonic mucosal biopsy specimens or those with inflammatory changes, but not to the extent encountered in this scenario. It is likely that this material represents cellular debris, presumably related to increased cell turnover at the epithelial–basement membrane junctional zone; such a feature may be suggestive of the diagnosis if confirmed in larger series.

Significant gastrointestinal problems are common in EB, with most studies showing up to 50% or more of the patients being affected.5 Constipation is the most common complaint, affecting about one third of patients; this frequent clinical problem is often due to the combination of recurrent anal fissuring together with a low fibre diet and poor fluid intake. Treatment in this group largely centres on polyethylene glycol products, such as low dose Movicol (1–2 sachets a day). Gastro‐oesophageal reflux is common in patients with dystrophic EB types and is the second most common gastrointestinal problem, being present in up to a third of all children with EB. Dysphagia, partly due to structuring, leads to great deal of morbidity in these children; recurrent dilatation, usually of the proximal oesophagus, is required, with most such cases of oesophageal strictures treated by balloon dilatation of the oesophagus under general anaesthesia.7

Those cases with colonic lamina propria karyorrhectic debris and inflammatory changes in their gastrointestinal biopsy specimens appear to represent a sub‐group of children primarily with recessive dystrophic EB. Diarrhoea is the most prominent lower gastrointestinal problem affecting 10% of these children, causing significant morbidity. Following demonstration of histological evidence of the presence of inflammation, as provided in this series, both anti‐inflammatory and immunosuppressive therapies, including sulphasalazine and slow weaning courses of prednisolone, have been used with significant subjective clinical improvement in symptoms.

figure cp35766.f1
Figure 1 Photomicrographs of colonic mucosal biopsy specimens from children with epidermolysis bullosa, showing non‐specific inflammatory changes, including eosinophils (A), focal mucosal haemosiderin laden macrophages (Perls stain; B), ...

We have reported the gastrointestinal mucosal biopsy findings in patients with EB, and shown that they may exhibit inflammatory changes, iron‐laden macrophages and a florid increase in colonic mucosal lamina propria karyorrhectic debris, predominantly in cases of recessive dystrophic EB. The mechanism underlying these changes remains to be elucidated but we hypothesise that the defective cell adhesion in this condition results in both altered epithelial cell turnover and abnormal mucosal permeability.

Footnotes

Competing interests: None declared.

References

1. Travis S P L, McGrath J A, Turnbull A J. et al Oral and gastrointestinal manifestations of epidermolysis bullosa. Lancet 1992. 3401505–1506.1506. [PubMed]
2. Orlando R C, Bozymski E M, Briggaman R A. et al Epidermolysis bullosa: gastrointestinal manifestations. Ann Intern Med 1974. 81203–206.206. [PubMed]
3. Lohi J, Leivo I, Tani T. et al Laminins, tenascin and type V11 collagen in colorectal mucosa. Histochem J 1996. 28431–440.440. [PubMed]
4. Horn H M, Tidman M J. The clinical spectrum of dystrophic epidermolysis bullosa. Br J Dermatol 2002. 146267–274.274. [PubMed]
5. Gryboski J D, Touloukian R, Campanella R A. Gastrointestinal manifestations of epidermolysis bullosa in children. Arch Dermatol 1988. 124746–752.752. [PubMed]
6. Mayhew T M, Myklebust R, Whybrow A. et al Epithelial integrity, cell death and cell loss in mammalian small intestine. Histol Histopathol 1999. 14257–267.267. [PubMed]
7. Castillo R O, Davies Y K, Lin Y C. et al Management of esophageal strictures in children with recessive dystrophic epidermolysis bullosa. J Pediatr Gastroenterol Nutr 2002. 34535–541.541. [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Group